The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
The CDMO business will be structured into three new business platforms designed to create a unified organization: Integrated Biologics, Advanced Synthesis, and Specialized Modalities
Poor oral health (periodontal disease) impacts nearly 51% of Indians
Ami informs that PMDA Japan has issued Inspection Result Report declaring the Sachin facility as a Good Manufacturing Practices (GMP) compliant.
Stressed was on the need to promote organ donation from the deceased persons to meet the huge need for organ donation in the country
The grant is designated for the research and development of Pyronaridine
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
Q1FY25 Revenue from Operations grew by 15% to Rs. 177 crore
Nearly 200 participants from 50 Unani Academia and Council participated
Subscribe To Our Newsletter & Stay Updated
